Grove Biopharma is a private biotechnology company advancing its Bionic Biologics platform, developing therapies targeting previously intractable intra...
(RTTNews) - Abbott (ABT) announced data from the AVEIR Conduction System Pacing acute clinical feasibility study, which demonstrated the safety and per...
Evotec SE, a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and m...
(RTTNews) - Abbott (ABT) announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pu...
Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Paci...
/PRNewswire/ -- Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patient...
In This Article: Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2025 Results Key Financial Results Revenue: US$11.2b (down 5.6% from 1Q 2024). Net inc...
Frequently Asked Questions about LRP Publications
Who are LRP Publications's top competitors?
LRP Publications's top 3 competitors are Paxen, MVC Associates International, Yash Solutions.
Who is similar to LRP Publications?
Paxen is the most similar to LRP Publications. MVC Associates International and Yash Solutions are also similar to LRP Publications.
Are LRP Publications and Paxen competitors?
Yes, Paxen is one of LRP Publications’s top competitors.